These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 2771990

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intravesical Bacillus Calmette Guerin therapy in patients with superficial bladder tumor.
    Steg A, Belas M, Leleu C, Boccon-Gibod L.
    Prog Clin Biol Res; 1989; 303():375-81. PubMed ID: 2780654
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J, Crego M, Sabaté S, Salvador J, Palou J, Villavicencio H.
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term effect of intravesical bacillus Calmette-Guérin (BCG) Tice strain on flat carcinoma in situ of the bladder.
    Reitsma DJ, Guinan P, Lamm DL, Khanna OP, Brosma SA, DeKernion JB, Williams RD, Sipmson G, Hanna MG.
    Prog Clin Biol Res; 1989 Jul; 310():171-85. PubMed ID: 2672014
    [No Abstract] [Full Text] [Related]

  • 10. [Intravesical instillations of BCG and bladder carcinoma in situ].
    Haab F, Dauge MC, Delmas V, Boccon-Gibod L.
    Prog Urol; 1993 Dec; 3(6):988-94; discussion 992-3. PubMed ID: 8305942
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Intravesical bacillus Calmette-Guerin therapy for superficial bladder tumor: experience of 13 cases].
    Okuno H, Shirahase T, Kihara Y, Arai Y.
    Hinyokika Kiyo; 1989 Sep; 35(9):1503-7. PubMed ID: 2816616
    [Abstract] [Full Text] [Related]

  • 14. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
    Herr HW.
    J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743
    [Abstract] [Full Text] [Related]

  • 15. [Intravesical BCG vaccine in bladder cancer].
    Beisland HO, Sander S.
    Tidsskr Nor Laegeforen; 1989 Jun 20; 109(17-18):1891-2. PubMed ID: 2749672
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of carcinoma in situ of the urinary bladder with BCG].
    Schnyder von Wartensee M, Ackermann D, Studer UE, Zingg EJ.
    Helv Chir Acta; 1989 Aug 20; 56(3):351-4. PubMed ID: 2807965
    [Abstract] [Full Text] [Related]

  • 17. [T1 G3 bladder tumors: the respective role of BCG and cystectomy].
    Pfister C, Landé P, Hervé JM, Barré P, Barbagelatta M, Camey M, Botto H.
    Prog Urol; 1995 Apr 20; 5(2):231-7. PubMed ID: 7719369
    [Abstract] [Full Text] [Related]

  • 18. [Low-dose BCG in the therapy of superficial neoplasms of the bladder].
    Francesco Bassi P, Milani C, Meneghini A, Maruzzi D, Garbeglio A, Aragona F, Tejerizo JC, Pagano F.
    Arch Esp Urol; 1990 Jun 20; 43(5):503-7. PubMed ID: 2202264
    [Abstract] [Full Text] [Related]

  • 19. [Our experience in the treatment of superficial cancer of the bladder with BCG].
    Martínez E, Díaz I, Salvador J, Viladoms JM, Zungri E, Solé-Balcells FJ.
    Arch Esp Urol; 1989 May 20; 42(4):325-7. PubMed ID: 2782959
    [Abstract] [Full Text] [Related]

  • 20. [Treatment and follow-up of superficial bladder cancer].
    Raitanen M.
    Duodecim; 2002 May 20; 118(9):903-9. PubMed ID: 12238168
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.